Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Cash from Operations: 2019-2024

Historic Cash from Operations for Praxis Precision Medicines (PRAX) over the last 6 years, with Dec 2024 value amounting to -$131.8 million.

  • Praxis Precision Medicines' Cash from Operations fell 136.57% to -$65.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$228.9 million, marking a year-over-year decrease of 130.02%. This contributed to the annual value of -$131.8 million for FY2024, which is 18.55% down from last year.
  • Per Praxis Precision Medicines' latest filing, its Cash from Operations stood at -$131.8 million for FY2024, which was down 18.55% from -$111.1 million recorded in FY2023.
  • Praxis Precision Medicines' 5-year Cash from Operations high stood at -$52.6 million for FY2020, and its period low was -$185.0 million during FY2022.
  • Moreover, its 3-year median value for Cash from Operations was -$131.8 million (2024), whereas its average is -$142.6 million.
  • Per our database at Business Quant, Praxis Precision Medicines' Cash from Operations plummeted by 136.69% in 2021 and then skyrocketed by 39.94% in 2023.
  • Yearly analysis of 5 years shows Praxis Precision Medicines' Cash from Operations stood at -$52.6 million in 2020, then plummeted by 136.69% to -$124.6 million in 2021, then tumbled by 48.56% to -$185.0 million in 2022, then spiked by 39.94% to -$111.1 million in 2023, then declined by 18.55% to -$131.8 million in 2024.